Molecular therapy for cancer: Withaferin, an arthritis drug, suppresses the expression of tumor suppressor Fbxw7 via up regulation of its target gene, 5/May/2014, 6.44 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular therapy for cancer: Withaferin, an arthritis drug, suppresses the expression of tumor suppressor Fbxw7 via up regulation of its target gene,  5/May/2014, 6.44 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org

Withaferin, an arthritis drug, suppresses the expression of oncogenic SMAD7 via up regulation of its target gene, 5/May/2014, 6.04 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Withaferin, an arthritis drug, suppresses the expression of oncogenic SMAD7 via up regulation of its target gene,  5/May/2014, 6.04 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org

Mechanistic insights into enhanced generation of iPSCs: Withaferin, an arthritis drug, promotes reprogramming of differentiated cells to iPSCs, 5/May/2014, 5.55 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Mechanistic insights into enhanced generation of iPSCs: Withaferin, an arthritis drug, promotes reprogramming of differentiated cells to iPSCs,  5/May/2014, 5.55 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org

Molecular cancer therapy: Cucurbitacin I (JSI-124) suppresses the expression of activator protein-1 via down regulation of its target gene, 5/May/2014, 5.47 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Cucurbitacin I (JSI-124) suppresses the expression of activator protein-1 via down  regulation of its target  gene,  5/May/2014, 5.47 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of Interleukin-2 via down regulation of its target gene, 05/May/2014, 5.44 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression  of Interleukin-2  via down regulation of its target gene, 05/May/2014, 5.44 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org

Fulvestrant, a selective estrogen receptor down-regulator, increases the expression of TNFα via down regulation of its target gene, 5/May/2014, 5,43 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Fulvestrant, a selective estrogen receptor down-regulator, increases the expression of TNFα via down regulation of its target gene, 5/May/2014, 5,43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation